Otonomy Appoints Chief Compliance Officer

By CW Staff2015-05-18T16:15:00

Otonomy, a clinical-stage bio-pharmaceutical company, has appointed Eric Loumeau as general counsel and chief compliance officer. Previously, Loumeau also served as general counsel and chief compliance officer for Hollis-Eden Pharmaceuticals, a publicly-traded biotechnology company. Details inside.

THIS IS MEMBERS-ONLY CONTENT

JOIN NOW

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.

“For tracking litigation, enforcement, and regulatory developments, Compliance Weekshould be your prime source.”

Otonomy Appoints Chief Compliance Officer

THIS IS MEMBERS-ONLY CONTENT

“For tracking litigation, enforcement, and regulatory developments, Compliance Week
should be your prime source.”